Celon Pharma Future Growth

How is Celon Pharma forecast to perform in the next 1 to 3 years based on estimates from 3 analysts?

Future Growth Score

1/6

Future Growth Score 1/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


-33.2%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLN is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CLN is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CLN is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CLN's revenue (5.3% per year) is forecast to grow faster than the Polish market (3.6% per year).

High Growth Revenue: CLN's revenue (5.3% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CLN is forecast to be unprofitable in 3 years.


Discover growth companies